Luminex adopts shareholder rights plan:
This article was originally published in Clinica
Executive Summary
Luminex has adopted a rights plan intended to protect its shareholders from hostile takeover attempts. The company, which develops biological testing technologies, says the development is not in response to any accumulation of shares or unsolicited bid. The plan would be triggered if an acquiring party accumulated 20% or more of the company's stock.